Skip to main content
. 2022 Dec 6;33(1):387–396. doi: 10.1007/s11695-022-06381-6

Table 1.

Assessments performed and data collected

Visit Assessments/data collected
Screening/baseline

• Informed consent and inclusion/exclusion criteria assessed

• Demographics (date of birth, gender, race)

• Height and weight

• GERD history: duration of PPI use, years with GERD, GERD new onset or pre-existing after LSG

• GERD-HRQL (on/off PPIs) and Foregut Symptoms Questionnaire (off PPIs)

• Baseline GERD-related medication use

• Esophageal pH measurements (off PPIs)

• Endoscopy

• Manometry/motility

• Barium esophagram

• Motivation for surgery

Implant/discharge

• Surgery date

• Surgery start and stop time

• Implanted device size

• Concomitant procedures (e.g., hiatal hernia repair, cholecystectomy)

• Barium esophagram and upright Bi-Planar X-Rays (AP and Lateral)

• Discharge date

• Perioperative and device- and/or procedure-related adverse events

2-week • Device- and/or procedure-related adverse events
3-month

• GERD-related medication usage within the last 30 days

• GERD-HRQL (off PPIs) and Foregut Symptoms Questionnaire (off PPIs)

• Device- and/or procedure-related adverse events

6-month

• GERD-related medication use within the last 30 days

• GERD-HRQL (off PPIs) and Foregut Symptoms Questionnaire (off PPIs)

• Device- and/or procedure-related adverse events

12-month

• Height and weight

• GERD-HRQL (off PPIs) and Foregut Symptoms Questionnaire (off PPIs)

• GERD-related medication usage within the last 30 days

• Esophageal pH testing (off PPIs)

• Manometry/motility

• Endoscopy

• Barium esophagram and upright Bi-Planar X-Rays

• Device- and/or procedure-related adverse events